Abcellera Biologics

ABCL · NASDAQ

$11.71−$0.22 (−1.84%)TodayMarket closed ·
Prev close $11.93

Who owns ABCL

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 47.8% of ABCL’s shares.

  • Thermopylae Holdings Ltd18.4%
  • Baker Bros. Advisors LP10.8%
  • Capital World Investors4.4%
  • Two Sigma Investments, LP3.4%
  • Next 6 largest institutions10.7%
  • All other shareholders52.2%
Top institutional holders of ABCL
HolderShares% of shares
Thermopylae Holdings Ltd56.13M18.38%
Baker Bros. Advisors LP33.01M10.81%
Capital World Investors13.59M4.45%
Two Sigma Investments, LP10.44M3.42%
Lecault (Veronique)9.61M3.15%
TD Waterhouse Canada, Inc.9.57M3.13%
ArrowMark Colorado Holdings, LLC4.11M1.34%
Bank of America Private Bank3.54M1.16%
UBS Asset Management (Americas) LLC3.08M1.01%
Driehaus Capital Management, LLC2.86M0.94%

Largest mutual fund holders

Top mutual fund holders of ABCL
HolderShares% of shares
American Funds SMALLCAP World Fund13.23M4.33%
Acatis - Datini Valueflex Fonds1.86M0.61%
UBS (Lux) Digital Health Equity Fund1.76M0.58%
iShares Biotechnology ETF1.75M0.57%
Counterpoint Quantitative Equity ETF1.16M0.38%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $1.64M (5 trades) of ABCL on the open market, with no sales.

Latest ABCL insider transactions
InsiderTypeSharesValue
Hayden Michael RBuy53.61K$570.44K
Montalbano John S.Buy10.00K$110.30K
Booth AndrewBuy37.20K$383.90K
Hayden Michael RBuy46.39K$481.03K
Hayden Michael RGift50.00K—
Sandor VictorAward152.21K—
Seely LynnAward152.21K—
Montalbano John S.Award111.70K—
Quake StephenAward111.70K—
Hayden Michael RAward111.70K—

Short interest

Settled Sep 30, 2026

Shares short
32.50M
Days to cover
5.98
% of shares outstanding
10.64%
Average daily volume
5.43M
Change since last report
−4.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.